GOSS
Price
$0.82
Change
-$0.04 (-4.65%)
Updated
Apr 16, 2:23 PM EST
28 days until earnings call
PASG
Price
$1.23
Change
-$0.00 (-0.00%)
Updated
Apr 15, 6:59 PM EST
27 days until earnings call
Ad is loading...

GOSS vs PASG ᐉ Comparison: Which is Better to Invest?

Header iconGOSS vs PASG Comparison
Open Charts GOSS vs PASGBanner chart's image
Gossamer Bio
Price$0.82
Change-$0.04 (-4.65%)
Volume$500
CapitalizationN/A
Passage Bio
Price$1.23
Change-$0.00 (-0.00%)
Volume$56.51K
CapitalizationN/A
View a ticker or compare two or three
GOSS vs PASG Comparison Chart

Loading...

GOSSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PASGDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
GOSS vs. PASG commentary
Apr 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOSS is a Hold and PASG is a Sell.

COMPARISON
Comparison
Apr 16, 2024
Stock price -- (GOSS: $0.86 vs. PASG: $1.23)
Brand notoriety: GOSS and PASG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GOSS: 57% vs. PASG: 22%
Market capitalization -- GOSS: $193.98M vs. PASG: $78.25M
GOSS [@Biotechnology] is valued at $193.98M. PASG’s [@Biotechnology] market capitalization is $78.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $559.84B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GOSS’s FA Score shows that 0 FA rating(s) are green whilePASG’s FA Score has 1 green FA rating(s).

  • GOSS’s FA Score: 0 green, 5 red.
  • PASG’s FA Score: 1 green, 4 red.
According to our system of comparison, both GOSS and PASG are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GOSS’s TA Score shows that 4 TA indicator(s) are bullish while PASG’s TA Score has 2 bullish TA indicator(s).

  • GOSS’s TA Score: 4 bullish, 5 bearish.
  • PASG’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, GOSS is a better buy in the short-term than PASG.

Price Growth

GOSS (@Biotechnology) experienced а -20.55% price change this week, while PASG (@Biotechnology) price change was -8.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.26%. For the same industry, the average monthly price growth was +2.36%, and the average quarterly price growth was +1239.38%.

Reported Earning Dates

GOSS is expected to report earnings on May 14, 2024.

PASG is expected to report earnings on May 13, 2024.

Industries' Descriptions

@Biotechnology (-3.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for GOSS with price predictions.
OPEN
A.I.dvisor published
a Summary for PASG with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
GOSS($194M) has a higher market cap than PASG($78.2M). PASG YTD gains are higher at: 21.782 vs. GOSS (-5.962).
GOSSPASGGOSS / PASG
Capitalization194M78.2M248%
EBITDAN/AN/A-
Gain YTD-5.96221.782-27%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
GOSSPASG
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 16 days ago
81%
Bullish Trend 20 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
View a ticker or compare two or three
Ad is loading...
GOSSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PASGDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TGRGX8.29-0.03
-0.36%
Transamerica International Focus I
MUARX12.05-0.09
-0.74%
Pioneer Equity Premium Income R
BNAFX8.25-0.07
-0.84%
Baron New Asia Retail
GCMCX28.09-0.27
-0.95%
Goldman Sachs Mid Cap Value C
CCRZX14.26-0.18
-1.25%
Columbia Disciplined Core Inst

GOSS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GOSS has been loosely correlated with MEIP. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GOSS jumps, then MEIP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GOSS
1D Price
Change %
GOSS100%
-4.14%
MEIP - GOSS
46%
Loosely correlated
-0.61%
CGEM - GOSS
45%
Loosely correlated
-0.72%
VIR - GOSS
43%
Loosely correlated
-4.46%
SYRE - GOSS
41%
Loosely correlated
-0.77%
APVO - GOSS
41%
Loosely correlated
-7.35%
More

PASG and

Correlation & Price change

A.I.dvisor indicates that over the last year, PASG has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PASG jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PASG
1D Price
Change %
PASG100%
-8.21%
AXON - PASG
43%
Loosely correlated
-2.41%
CYTK - PASG
38%
Loosely correlated
-4.97%
ARRY - PASG
35%
Loosely correlated
-6.18%
SNPX - PASG
32%
Poorly correlated
-5.69%
CMPX - PASG
31%
Poorly correlated
-2.47%
More